Spironolactone has been shown to reduce QT dispersion in chronic heart failure[23] and it is of interest to investigate whether this is also the case in hypertension and whether such an effect is more prominent in subjects with a high aldosterone: renin ratio. The gene discussed is REN; the disease is hypertensive disorder.